Treatment of acute stroke: an update (Q38541197)

4 September 2017

1 reference

title

Treatment of acute stroke: an update (English)

1 reference

4 September 2017

R Mikulik

1 reference

4 September 2017

N Wahlgren

series ordinal

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

Journal of Internal Medicine

4 September 2017

published in

1 reference

4 September 2017

volume

278

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

145-165

1 reference

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The global burden of disease study: implications for neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Comparison of clinical and neuroradiological findings in first-ever stroke. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Classification and natural history of clinically identifiable subtypes of cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombectomy within 8 hours after symptom onset in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Endovascular therapy for ischemic stroke with perfusion-imaging selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Randomized assessment of rapid endovascular treatment of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A randomized trial of intraarterial treatment for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Time Is Brain--Quantified

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Accuracy of serial National Institutes of Health Stroke Scale scores to identify artery status in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Definition and Evaluation of Transient Ischemic Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Transient ischemic attack--proposal for a new definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A trial of imaging selection and endovascular treatment for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolytic therapy with streptokinase in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Is thrombolysis safe in the elderly?: analysis of a national database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Intravenous alteplase for stroke in those older than 80 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Outcome of patients with negative CT angiography results for arterial occlusion treated with intravenous thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia: analysis of Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Recanalization after thrombolysis in stroke patients: predictors and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Neurothrombectomy for the treatment of acute ischemic stroke: results from the TREVO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Endovascular treatment for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The impact of recanalization on ischemic stroke outcome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Outcome of stroke with mild or rapidly improving symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Argatroban tPA stroke study: study design and results in the first treated cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Low-Power 2-MHz Pulsed-Wave Transcranial Ultrasound Reduces Ischemic Brain Damage in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A pilot study on systemic thrombolysis followed by low molecular weight heparin in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Dosing of tissue plasminogen activator often differs from 0.9 mg/kg, but does not affect the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Factors influencing in-hospital delay in treatment with intravenous thrombolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Calling emergency medical services for acute stroke: a study of 9-1-1 tapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Which stroke symptoms prompt a 911 call? A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Calling 911 in response to stroke: a nationwide study assessing definitive individual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Calling 911 in response to stroke: no change following a four-year educational campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The identification of acute stroke: an analysis of emergency calls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Recombinant activated factor VII for acute intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Hyperglycemia in stroke and possible treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Hyperthermia in human ischemic and hemorrhagic stroke: similar outcome, different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Endovascular therapeutic hypothermia for acute ischemic stroke: ICTuS 2/3 protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Feasibility of endovascular and surface cooling strategies in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Neuroprotection for ischaemic stroke: translation from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12387

21 January 2018

Identifiers

DOI

10.1111/JOIM.12387

1 reference

4 September 2017

1 reference